click below
click below
Normal Size Small Size show me how
0 ms
week 3
| Question | Answer |
|---|---|
| Closure or collapse of alveoli resulting in reduced alveolar ventilation. | Atelectasis |
| Atelectasis that is not detectable on chest X-ray. | Microatelectasis |
| Atelectasis involving loss of segmental, lobar, or overall lung volume. | Macroatelectasis |
| Most commonly detected type of atelectasis. | Acute atelectasis |
| Deep breathing exercises should be performed every ________ hours to prevent atelectasis. | 2 hours |
| Therapy using a one-way valve system that provides expiratory resistance. | Positive Expiratory Pressure (PEP) Therapy |
| : Inflammation of the lung parenchyma caused by a microbial agent. | Pneumonia |
| Two major categories of pneumonia. | Community-Acquired Pneumonia (CAP) and Hospital-Acquired Pneumonia (HAP) |
| Most common cause of Community-Acquired Pneumonia. | Streptococcus pneumoniae |
| Pneumonia common in children and young adults transmitted through respiratory droplets. | Mycoplasma pneumonia |
| Common pneumonia pathogen in older adults with comorbid illnesses. | Haemophilus influenzae |
| Another term for Hospital-Acquired Pneumonia. | Nosocomial pneumonia |
| Pneumonia symptoms occurring more than ________ hours after hospital admission indicate HAP. | 48 hours |
| Pneumonia commonly seen in debilitated patients. | Pseudomonal pneumonia |
| Pneumonia caused by inhalation of organisms. | Staphylococcal pneumonia |
| Entry of endogenous or exogenous substances into the lower airway causing pneumonia. | Aspiration pneumonia |
| Pneumonia involving a substantial portion of one or both lungs. | Lobar pneumonia |
| Patchy pneumonia originating in bronchi and extending to adjacent lung tissue. | Bronchopneumonia |
| Blue discoloration of lips and nail beds seen in severe pneumonia. | Central cyanosis |
| Difficulty breathing while lying flat. | Orthopnea |
| Diagnostic test used to identify bacteremia in pneumonia. | Blood culture |
| Examination used to obtain respiratory specimens directly from airways. | Bronchoscopy |
| Infectious disease that primarily affects the lung parenchyma. | Pulmonary Tuberculosis (PTB) |
| Test used to determine exposure to the TB bacillus. | Mantoux Test |
| Amount of PPD injected during Mantoux test. | 0.1 mL |
| Mantoux test results are read after ________ | 48–72 hours |
| Mantoux result considered not significant. | 0–4 mm |
| Mantoux result significant in high-risk individuals. | 5 mm |
| TB Classification: No exposure and no infection. | Class 0 |
| TB Classification: Exposure but no evidence of infection. | Class 1 |
| TB Classification: Latent infection without disease. | Class 2 |
| TB Classification: Clinically active disease. | Class 3 |
| TB Classification: Disease not clinically active. | Class 4 |
| TB Classification: Suspected disease, diagnosis pending. | Class 5 |
| Anti-TB medication that should be taken on an empty stomach and requires avoidance of tyramine-rich foods. | Isoniazid (INH) |